Xencor Doses First Patient in Phase 1 Study of XmAb23104 for the Treatment of Patients with Advanced Solid Tumors Read more
FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis Read more
Skyhawk Therapeutics Announces Agreement with Takeda to Develop Novel Small Molecule RNA Splicing Modifiers for Neurodegenerative Diseases Read more
Samsung BioLogics signed CDO(Contract Development Organization) contract with GI Innovation Read more
AMAL Therapeutics Enters Clinical Collaboration with Boehringer Ingelheim to Evaluate ATP128 in Combination with BI754091 Read more